[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @matthewherper Matthew Herper Matthew Herper posts on X about $srpt, sarepta therapeutics, stocks, positions the most. They currently have XXXXXXX followers and XX posts still getting attention that total XXXXXX engagements in the last XX hours. ### Engagements: XXXXXX [#](/creator/twitter::44438256/interactions)  - X Week XXXXXX +261% - X Month XXXXXXX -XX% - X Months XXXXXXXXX +18% - X Year XXXXXXXXX -XX% ### Mentions: XX [#](/creator/twitter::44438256/posts_active)  - X Week XX +9.50% - X Month XX +39% - X Months XXX -XX% - X Year XXX +68% ### Followers: XXXXXXX [#](/creator/twitter::44438256/followers)  - X Week XXXXXXX +0.09% - X Month XXXXXXX +0.18% - X Months XXXXXXX -XXXX% - X Year XXXXXXX -X% ### CreatorRank: XXXXXXX [#](/creator/twitter::44438256/influencer_rank)  ### Social Influence [#](/creator/twitter::44438256/influence) --- **Social category influence** [stocks](/list/stocks) XX% [finance](/list/finance) XXXX% [countries](/list/countries) XXXX% **Social topic influence** [$srpt](/topic/$srpt) #4, [sarepta therapeutics](/topic/sarepta-therapeutics) 6.67%, [stocks](/topic/stocks) 3.33%, [positions](/topic/positions) 3.33%, [rates](/topic/rates) 3.33%, [united states](/topic/united-states) 3.33%, [trumps](/topic/trumps) 3.33%, [marks](/topic/marks) 3.33%, [neat](/topic/neat) 3.33%, [cart](/topic/cart) XXXX% **Top accounts mentioned or mentioned by** [@adamfeuerstein](/creator/undefined) [@dtrmweihe](/creator/undefined) [@ruxandrateslo](/creator/undefined) [@elainychen](/creator/undefined) [@mbeisen](/creator/undefined) [@peterbachmd](/creator/undefined) [@sanctuarybio](/creator/undefined) [@buysidebio](/creator/undefined) [@jburnmurdoch](/creator/undefined) [@daphnezohar](/creator/undefined) [@jasonmmast](/creator/undefined) [@theprofessor85](/creator/undefined) [@ejsmd](/creator/undefined) [@alnylam](/creator/undefined) [@bluejaunt100](/creator/undefined) [@amandagarces](/creator/undefined) [@masterlongevity](/creator/undefined) [@jasonukman](/creator/undefined) [@mbrushstocks](/creator/undefined) [@dsobek](/creator/undefined) **Top assets mentioned** [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [AbbVie Inc (ABBV)](/topic/$abbv) ### Top Social Posts [#](/creator/twitter::44438256/posts) --- Top posts by engagements in the last XX hours "Sarepta Therapeutics has refused the FDAs request that it pull gene therapy from the market following patient deaths"  [@matthewherper](/creator/x/matthewherper) on [X](/post/tweet/1946352660820500900) 2025-07-18 23:33:30 UTC 109.5K followers, 5405 engagements "I've known Adam for XX years and worked with him for six and he's a great journalist. Comments like this reveal the commenter doesn't understand the first thing about how the world works. Doctors generally make much more than journalists. I know doctors who make more than Grayden Carter did at Vanity Fair We're forbidden from having positions in stocks or sharing inside information outside of our reporting and stories and journalists who do are not only fired sometimes they go to jail. You could run a whole newsroom on what many biotech CEOs make annually. Sarepta itself has annual revenues"  [@matthewherper](/creator/x/matthewherper) on [X](/post/tweet/1947008176190070785) 2025-07-20 18:58:17 UTC 109.5K followers, 14.2K engagements "Amgens obesity drug led to high discontinuation rates in mid-stage trial as company plans to adjust dosing @elainychen writes"  [@matthewherper](/creator/x/matthewherper) on [X](/post/tweet/1937219147416379577) 2025-06-23 18:40:11 UTC 109.5K followers, 3075 engagements "@mbeisen Ah. I read it as the *bold* they. Carry on"  [@matthewherper](/creator/x/matthewherper) on [X](/post/tweet/1947073901860618481) 2025-07-20 23:19:27 UTC 109.5K followers, XXX engagements "@adamfeuerstein Fun exercise: how many of those purchases were bad ones"  [@matthewherper](/creator/x/matthewherper) on [X](/post/tweet/1944890855199756479) 2025-07-14 22:44:48 UTC 109.5K followers, 2009 engagements "A former Pfizer scientist denied an allegation made by House Republicans that he conspired to delay the release of Covid shot data to hurt Trumps 2020 election prospects In his letter Phil Dormitzer said he has left the country due to the dismantling of vaccine science in the United States"  [@matthewherper](/creator/x/matthewherper) on [X](/post/tweet/1945231011731710254) 2025-07-15 21:16:28 UTC 109.5K followers, 3609 engagements "Read this updated story on $srpt with comments from Peter Marks and @daphnezohar by @adamfeuerstein and @Jasonmmast"  [@matthewherper](/creator/x/matthewherper) on [X](/post/tweet/1946309910154592492) 2025-07-18 20:43:37 UTC 109.5K followers, 4804 engagements "So @adamfeuerstein says $SRPT may not survive and I think his argument is crisp and cogent"  [@matthewherper](/creator/x/matthewherper) on [X](/post/tweet/1948370287583449269) 2025-07-24 13:10:50 UTC 109.5K followers, 15.8K engagements "FDA to request Sarepta Therapeutics halt shipments of Duchenne gene therapy"  [@matthewherper](/creator/x/matthewherper) on [X](/post/tweet/1946262002067734745) 2025-07-18 17:33:15 UTC 109.5K followers, 2445 engagements "New story FDA Commissioner Marty Makary has tossed off a lot of neat sounding proposals over his first term. Only one impresses me: the promise to post FDA rejection letters. But linking his new two-month vouchers to cuts in drug prices That idea doesn't hold up to basic economics"  [@matthewherper](/creator/x/matthewherper) on [X](/post/tweet/1944720889695637532) 2025-07-14 11:29:25 UTC 109.5K followers, 3123 engagements "Dispatch Bio raises $XXX million for solid tumor immunotherapy Solid tumors have challenged CAR-T developers Sean Parker ARCH launch biotech developing a universal immunotherapy"  [@matthewherper](/creator/x/matthewherper) on [X](/post/tweet/1947980762822635861) 2025-07-23 11:23:00 UTC 109.5K followers, 7760 engagements "A Saturday thought: If the FDA wants to force Sarepta Therapeutics ( $SRPT ) to remove its Duchenne gene therapy Elevidys from the market entirely it could be a long fight. That the FDA has asked Sarepta to stop shipping Elevidys is unusual; that $SRPT has refused is almost unprecedented. I can think of two cases in XX years. Genentech's Avastin had accelerated approval for breast cancer. After postmarketing trials showed neither safety nor efficacy the FDA sought to remove it in 2010. There was an adcomm that July that voted for removal followed by a two-day public hearing in June 2011"  [@matthewherper](/creator/x/matthewherper) on [X](/post/tweet/1946632083327340678) 2025-07-19 18:03:49 UTC 109.5K followers, 42.7K engagements "Peter Thiel's Firm Backed A Biotech. Big Pharma Bought It. It Blew Up"  [@matthewherper](/creator/x/matthewherper) on [X](/post/news/forbes.com-2237511237) 2025-04-15 14:20:51 UTC 109.5K followers, XXX engagements "Weight-loss drug use in kids surged after doctors' recommendation"  [@matthewherper](/creator/x/matthewherper) on [X](/post/tweet/1945115670229741847) 2025-07-15 13:38:08 UTC 109.5K followers, 2564 engagements "The crisis over Sareptas Duchenne therapy is a mess. But the lesson is clear No matter how the situation is resolved this is no way to do drug development It is a way to leave me depressed. I sat down and hammered out my thoughts on the current $SRPT situation. You can find them here:"  [@matthewherper](/creator/x/matthewherper) on [X](/post/tweet/1947362109131788447) 2025-07-21 18:24:41 UTC 109.5K followers, 5222 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@matthewherper Matthew Herper
Matthew Herper posts on X about $srpt, sarepta therapeutics, stocks, positions the most. They currently have XXXXXXX followers and XX posts still getting attention that total XXXXXX engagements in the last XX hours.
Engagements: XXXXXX #
- X Week XXXXXX +261%
- X Month XXXXXXX -XX%
- X Months XXXXXXXXX +18%
- X Year XXXXXXXXX -XX%
Mentions: XX #
- X Week XX +9.50%
- X Month XX +39%
- X Months XXX -XX%
- X Year XXX +68%
Followers: XXXXXXX #
- X Week XXXXXXX +0.09%
- X Month XXXXXXX +0.18%
- X Months XXXXXXX -XXXX%
- X Year XXXXXXX -X%
CreatorRank: XXXXXXX #
Social Influence #
Social category influence stocks XX% finance XXXX% countries XXXX%
Social topic influence $srpt #4, sarepta therapeutics 6.67%, stocks 3.33%, positions 3.33%, rates 3.33%, united states 3.33%, trumps 3.33%, marks 3.33%, neat 3.33%, cart XXXX%
Top accounts mentioned or mentioned by @adamfeuerstein @dtrmweihe @ruxandrateslo @elainychen @mbeisen @peterbachmd @sanctuarybio @buysidebio @jburnmurdoch @daphnezohar @jasonmmast @theprofessor85 @ejsmd @alnylam @bluejaunt100 @amandagarces @masterlongevity @jasonukman @mbrushstocks @dsobek
Top assets mentioned Sarepta Therapeutics, Inc. (SRPT) AbbVie Inc (ABBV)
Top Social Posts #
Top posts by engagements in the last XX hours
"Sarepta Therapeutics has refused the FDAs request that it pull gene therapy from the market following patient deaths"
@matthewherper on X 2025-07-18 23:33:30 UTC 109.5K followers, 5405 engagements
"I've known Adam for XX years and worked with him for six and he's a great journalist. Comments like this reveal the commenter doesn't understand the first thing about how the world works. Doctors generally make much more than journalists. I know doctors who make more than Grayden Carter did at Vanity Fair We're forbidden from having positions in stocks or sharing inside information outside of our reporting and stories and journalists who do are not only fired sometimes they go to jail. You could run a whole newsroom on what many biotech CEOs make annually. Sarepta itself has annual revenues" @matthewherper on X 2025-07-20 18:58:17 UTC 109.5K followers, 14.2K engagements
"Amgens obesity drug led to high discontinuation rates in mid-stage trial as company plans to adjust dosing @elainychen writes" @matthewherper on X 2025-06-23 18:40:11 UTC 109.5K followers, 3075 engagements
"@mbeisen Ah. I read it as the bold they. Carry on" @matthewherper on X 2025-07-20 23:19:27 UTC 109.5K followers, XXX engagements
"@adamfeuerstein Fun exercise: how many of those purchases were bad ones" @matthewherper on X 2025-07-14 22:44:48 UTC 109.5K followers, 2009 engagements
"A former Pfizer scientist denied an allegation made by House Republicans that he conspired to delay the release of Covid shot data to hurt Trumps 2020 election prospects In his letter Phil Dormitzer said he has left the country due to the dismantling of vaccine science in the United States" @matthewherper on X 2025-07-15 21:16:28 UTC 109.5K followers, 3609 engagements
"Read this updated story on $srpt with comments from Peter Marks and @daphnezohar by @adamfeuerstein and @Jasonmmast" @matthewherper on X 2025-07-18 20:43:37 UTC 109.5K followers, 4804 engagements
"So @adamfeuerstein says $SRPT may not survive and I think his argument is crisp and cogent" @matthewherper on X 2025-07-24 13:10:50 UTC 109.5K followers, 15.8K engagements
"FDA to request Sarepta Therapeutics halt shipments of Duchenne gene therapy" @matthewherper on X 2025-07-18 17:33:15 UTC 109.5K followers, 2445 engagements
"New story FDA Commissioner Marty Makary has tossed off a lot of neat sounding proposals over his first term. Only one impresses me: the promise to post FDA rejection letters. But linking his new two-month vouchers to cuts in drug prices That idea doesn't hold up to basic economics" @matthewherper on X 2025-07-14 11:29:25 UTC 109.5K followers, 3123 engagements
"Dispatch Bio raises $XXX million for solid tumor immunotherapy Solid tumors have challenged CAR-T developers Sean Parker ARCH launch biotech developing a universal immunotherapy" @matthewherper on X 2025-07-23 11:23:00 UTC 109.5K followers, 7760 engagements
"A Saturday thought: If the FDA wants to force Sarepta Therapeutics ( $SRPT ) to remove its Duchenne gene therapy Elevidys from the market entirely it could be a long fight. That the FDA has asked Sarepta to stop shipping Elevidys is unusual; that $SRPT has refused is almost unprecedented. I can think of two cases in XX years. Genentech's Avastin had accelerated approval for breast cancer. After postmarketing trials showed neither safety nor efficacy the FDA sought to remove it in 2010. There was an adcomm that July that voted for removal followed by a two-day public hearing in June 2011" @matthewherper on X 2025-07-19 18:03:49 UTC 109.5K followers, 42.7K engagements
"Peter Thiel's Firm Backed A Biotech. Big Pharma Bought It. It Blew Up" @matthewherper on X 2025-04-15 14:20:51 UTC 109.5K followers, XXX engagements
"Weight-loss drug use in kids surged after doctors' recommendation" @matthewherper on X 2025-07-15 13:38:08 UTC 109.5K followers, 2564 engagements
"The crisis over Sareptas Duchenne therapy is a mess. But the lesson is clear No matter how the situation is resolved this is no way to do drug development It is a way to leave me depressed. I sat down and hammered out my thoughts on the current $SRPT situation. You can find them here:" @matthewherper on X 2025-07-21 18:24:41 UTC 109.5K followers, 5222 engagements